Sign in Subscribe

Alex Chompff

Meta-analysis compares EGFR inhibitors versus bevacizumab for converting unresectable liver metastases

Skip to content The CRC Digest ▸ TREATMENT Meta-analysis compares EGFR inhibitors versus bevacizumab for converting unresectable liver metastases A systematic review and meta-analysis of randomized trials in patients with RAS wild-type colorectal liver metastases compared chemotherapy combined with EGFR inhibitors versus bevacizumab as first-line treatment, analyzing data from 795 patients

National study examines surveillance colonoscopy in Lynch syndrome patients

Skip to content The CRC Digest ▪ SCREENING National study examines surveillance colonoscopy in Lynch syndrome patients A national study of 4,732 Lynch syndrome carriers in the English NHS assessed adherence to surveillance guidelines and aimed to determine the impact of colonoscopic surveillance on colorectal cancer incidence and mortality in

CRC Research Update — August 06, 2026

Today's colorectal cancer research highlights

Shared Decision-Making Framework for CRC Screening Choices

Skip to content The CRC Digest Shared Decision-Making Framework for CRC Screening Choices A review emphasizes the importance of tailoring screening strategies to individual patient risk profiles and using shared decision-making to guide patients through screening choices based on age, family history, comorbidities, and psychosocial factors. (Clinical Colon and Rectal

Early-Onset CRC Among Young Latino Men Linked to Structural Inequities

Skip to content The CRC Digest Early-Onset CRC Among Young Latino Men Linked to Structural Inequities An editorial co-authored by a Latino cancer survivor diagnosed at age 38 examines how molecular epidemiology and structural inequities converge in early-onset colorectal cancer among young Latino men, who face diagnostic delays, lower screening

Study Examines Universal Tumor Screening for Lynch Syndrome in Japan

Skip to content The CRC Digest ▪ SCREENING Study Examines Universal Tumor Screening for Lynch Syndrome in Japan A prospective study of 591 patients with stage II/III colorectal cancer in Japan aimed to clarify the clinical utility and cost-effectiveness of universal tumor screening using immunohistochemistry to identify Lynch syndrome, with

KRAS Mutation Subtypes May Influence Response to Neoadjuvant Therapy in Rectal Cancer

Skip to content The CRC Digest ◇ RESEARCH KRAS Mutation Subtypes May Influence Response to Neoadjuvant Therapy in Rectal Cancer A meta-analysis investigated whether different KRAS mutation subtypes affect pathological complete response rates after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. The study examined KRAS mutations within and outside exon 2.

Financial and professional impacts persist for early-onset CRC survivors

Skip to content The CRC Digest Financial and professional impacts persist for early-onset CRC survivors A multicenter study across 7 academic medical centers found that patients diagnosed with colorectal cancer before age 50 experience lasting financial and professional instability, given their developmental stage in establishing careers and families. (Diseases of

AI tool identifies rectal cancer patients who benefit from intensified chemoradiotherapy

Skip to content The CRC Digest ◇ RESEARCH AI tool identifies rectal cancer patients who benefit from intensified chemoradiotherapy A post-hoc analysis of the phase III ARISTOTLE trial found that higher tumor cell density predicted improved survival in locally advanced rectal cancer patients receiving irinotecan-intensified neoadjuvant chemoradiotherapy; researchers developed a free

FDA approves second blood test to help close colorectal cancer screening gap

Skip to content The CRC Digest ● REGULATORY FDA approves second blood test to help close colorectal cancer screening gap The FDA has approved a second blood-based screening test for colorectal cancer, expanding options for patients who may avoid traditional colonoscopy. (AOL.com) This content is informational only and does not